Protection of Normal Tissue from the Cytotoxic Effects of Chemotherapy and Radiation by Amifostine: Clinical Experiences
- 31 December 1995
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31, S8-S13
- https://doi.org/10.1016/0959-8049(95)00144-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pilot trial of cisplatin, radiation, and WR2721 in carcinoma of the uterine cervix: a New York Gynecologic Oncology Group study.Journal of Clinical Oncology, 1993
- Biochemical modification of the toxicity and the anti-tumour effect of 5-fluorouracil and cis-platinum by WR-2721 in miceEuropean Journal Of Cancer, 1992
- Use of radiation with or without WR-2721 in advanced rectal cancerCancer, 1992
- Concomitant cisplatin and radiotherapy in locally advanced cervical carcinomaGynecologic Oncology, 1989
- Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721Cancer, 1988
- WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.Journal of Clinical Oncology, 1987
- Hypocalcemia and Inhibition of Parathyroid Hormone Secretion after Administration of WR-2721 (a Radioprotective and Chemoprotective Agent)New England Journal of Medicine, 1983